NYSE ARCA | ETF
Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities ofU. S. health care companies.
The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector.
The fund will typically invest in 50 " 100 health care companies.
The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 7.09% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 6.65% |
| PCT | Purecycle Technologies Holdings Corp | Industrials | Pollution & Treatment Controls | 5.59% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.14% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.89% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.86% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.69% |
| ADMA | ADMA Biologics Inc | Healthcare | Biotechnology | 4.65% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 4.65% |
| ALGN | Align Technology Inc | Healthcare | Medical Devices | 4.64% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.50% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 4.06% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.87% |
| NVO | Novo Nordisk A/S | Healthcare | Biotechnology | 3.70% |
| SWAV | Shockwave Medical Inc | Healthcare | Medical Devices | 3.58% |
| PM | Philip Morris International Inc | Consumer Defensive | Tobacco | 3.49% |
| AAVXF | ABIVAX Société Anonyme | Healthcare | Biotechnology | 3.30% |
| ARQT | Arcutis Biotherapeutics Inc | Healthcare | Biotechnology | 3.27% |
| EYE | National Vision Holdings Inc | Consumer Cyclical | Specialty Retail | 3.01% |
| RHHBY | Roche Holding Ltd ADR | Healthcare | Drug Manufacturers - General | 2.94% |